Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 02 1995, 331-335, Vol 33, No. 2
TR Shryock, DW White, CS Werner and JM Staples
Quality control guidelines for tilmicosin, a novel veterinary-use-only
macrolide, were developed in a multi-laboratory study according to
established National Committee for Clinical Laboratory Standards (NCCLS)
procedures (M23-T2). Tilmicosin was incorporated into Sensititre plates for
broth microdilution endpoint testing and into two lots of 15-micrograms
disks for Kirby-Bauer agar disk diffusion testing. One common lot and five
unique lots of Mueller-Hinton media were used. (Broth was cation adjusted,
and agar was supplemented with 5% defibrinated sheep blood.) Bacteria used
for reference strains included Pasteurella haemolytica 128K, Pasteurella
multocida ATCC 43137, and Staphylococcus aureus ATCC 29213 (microdilution)
and ATCC 25923 (disk). Replicate tests were conducted. Disk diffusion and
broth microdilution quality control ranges are proposed.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin
Lilly Research Laboratories, Eli Lilly and Company, Greenfield, Indiana 46140.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|